Atlas Trials

Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease

Clinical trial NCT06839820 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06839820
Sponsor
University Hospital, Akershus
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
InfliximabInfusionIBD (Inflammatory Bowel Disease)Patient Satisfaction
Start date
2025-02-01
Primary completion
2026-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.